1207538-11-1

Basic information

• Product Name: (2RS)-1-(4-ethylphenyl)-2-methyl-3-piperidin-1-yl-propan-1-one methansulfonate
• Synonyms: (2RS)-1-(4-ethylphenyl)-2-methyl-3-piperidin-1-yl-propan-1-one methansulfonate
• CAS NO: 1207538-11-1
• Molecular Weight: 355.499
• Mol File: 1207538-11-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (2RS)-1-(4-ethylphenyl)-2-methyl-3-piperidin-1-yl-propan-1-one methansulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: (2RS)-1-(4-ethylphenyl)-2-methyl-3-piperidin-1-yl-propan-1-one methansulfonate(1207538-11-1)
• EPA Substance Registry System: (2RS)-1-(4-ethylphenyl)-2-methyl-3-piperidin-1-yl-propan-1-one methansulfonate(1207538-11-1)

Safety Data

• Hazardous Substances Data: 1207538-11-1(Hazardous Substances Data)

Upstream product

• 64840-90-0 eperisone 
• 75-75-2 methanesulfonic acid 

Relevant articles and documents

NOVEL FORMS OF EPERISONE

The invention relates to substantially enantiopure crystalline salt forms of (2RS)-I -(4- Ethylphenyl)-2-methyl-3-piperidin-l-ylpropan-l-one. The preparation and characterization of the substantially enantiopure crystalline salt forms according to various embodiments of the invention is described. The invention also relates to pharmaceutical compositions containing the substantially enantiopure crystalline salt forms, which are useful to treat and/or prevent various conditions such as pathological muscle contracture, myotome conditions, and spastic paralysis or spasticity caused by various neurologic conditions, and are also useful for the treatment and/or prevention of various types of pain and pathological muscle tension.